MR WITNESS: A Study of Intravenous Thrombolysis With Alteplase in MRI-Selected Patients "MR WITNESS"

Active, not recruiting

Phase 2 Results N/A

Summary of Purpose

This study was jointly developed and is jointly led by investigators at Massachusetts General Hospital and the intramural division of NINDS. We are doing this research study to find out if Activase ® (also called alteplase or rt-PA) can safely be given to people with an acute ischemic stroke when their stroke onset was not witnessed making them ineligible for standard thrombolytic (clot busting) therapy. We also...

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 March 2016.

1 Jan 2011 19 Jan 2011 1 Jul 2016 1 Dec 2016 1 Mar 2016 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Conditions

Sponsors See All

Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety Study
  • Intervention: Single Group Assignment

Contacts

Not available